Literature DB >> 9008698

Sore throat after sore throat after sore throat. Are you asking the critical questions?

M E Pichichero1.   

Abstract

In this discussion of recurrent group A streptococcal tonsillopharyngitis, the author notes that even at the peak of the streptococcal infection season, not more than 30% to 40% of children with sore throats actually have group A streptococci as the cause. Thus, it is vital to confirm clinical diagnosis of group A streptococcal tonsillopharyngitis with laboratory tests. When patients have recurrent infections with group A streptococci, possible causes include noncompliance, bacterial resistance, repeated exposure, alteration of the throat's microbial ecology, suppression of antibody response due to previous antibiotic therapy, and treatment failure. When noncompliance is an issue, an injection of penicillin G benzathine may be appropriate. In other circumstances, pharmacologic options for treatment of recurrent group A streptococcal tonsillopharyngitis include macrolides, clindamycin hydrochloride, rifampin (in combination with a second agent), and oral cephalosporins. If a patient has six or seven recurrences over 1 or 2 years despite antibiotic treatment, tonsillectomy should be considered.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9008698     DOI: 10.3810/pgm.1997.01.150

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  3 in total

Review 1.  Role of the microbiology laboratory in diagnosis and management of pharyngitis.

Authors:  Paul P Bourbeau
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

Review 2.  Acute upper airway infections.

Authors:  J V West
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

3.  A study of group a streptococcal bacteria isolation from children less than 12 years with acute tonsillitis, pharyngitis and healthy primary school children.

Authors:  Abdulwahab M A Telmesani; Hani O Ghazi
Journal:  J Family Community Med       Date:  2002-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.